SCHEMBL845227

SCHEMBL845227

CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.76
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
NPSR1 Q6W5P4 2/20 0.60
LMNA P02545 1/20 0.60
JAK2 O60674 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPK1 P28482 1/20 0.53
HTT P42858 1/20 0.53
PTPN2 P17706 1/20 0.51
PTPN1 P18031 1/20 0.51
PTPN6 P29350 1/20 0.51
USP30 Q70CQ3 1/20 0.51
POLB P06746 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
PABPC1 P11940 1/20 0.50
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
EP300 Q09472 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10281278 1.00 NPC1 (0.76) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL10299164 1.00 NPC1 (0.76) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL13272185 0.90 NPC1 (0.63) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL844873 0.90 NPC1 (0.63) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL17474759 0.89 NPC1 (0.80) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL17474788 0.89 NPC1 (0.80) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL23373363 0.88 NPC1 (0.79) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL845258 0.88 MAPK1 (0.60) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL845611 0.88 NPC1 (0.59) NPC1MEN1KMT2ANPSR1LMNA
SCHEMBL1752676 0.87 NPC1 (0.77) NPC1MEN1KMT2ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed